About the

COSA offers the Best of the Best Awards at each of the Best of the Best Oral and Poster Sessions at the COSA Annual Scientific Meeting (ASM). Independent adjudicators award the prizes at the session based on the content, the importance of the research, and the quality of the presentation. The Best of the Best Oral Awards are for $1,000 in each session. Best of the Best Poster Awards are for $500 in each session.


To be eligible for an award you must:

2022 Best of the Best Oral Presentation Award recipients

Adam K Walker

Angiotensin receptor 1 blockade blocks cancer-induced memory impairment in a mouse model of breast cancer 

Amy Body

Immune response to COVID-19 vaccination in adults and children with cancer: results from the prospective SerOzNET study

Meredith Cummins

”Living with NETs” – online patient education program

Ieta D’Costa

The importance of understanding bias: why anti-racist measures are required for First Nations cancer care equity  

Visalini Nair-Shalliker

Cutaneous melanoma, prostate specific antigen testing and the subsequent risk of prostate cancer diagnosis: a prospective analysis of the 45 and Up Study

Abhijit Pal

Improving access to cancer clinical trials for patients from culturally and linguistically diverse (CALD) backgrounds – results of a national survey, part 3

Chloe L Georgiou

The Australian Rare Cancer Portal: outcomes from the implementation of a national rare cancer platform for referrals and research

Lara Edbrooke

Exercise across the lung cancer care continuum: an overview of systematic reviews

Vincent Singh Paramanandam

Role of the compression sleeves in the prevention of breast cancer-related lymphoedema: A randomised controlled trial 

2022 Best of the Best Poster Oral Presentation Award recipients

Ursula M Sansom-Daly

Improving end-of-life communication for all adolescents and young adults with cancer: a multi-perspective, mixed methods evaluation of the Voicing My CHOICESTM tool 

Lauren Hanna

Relationship between circulating tumour DNA and skeletal muscle stores at diagnosis of pancreatic ductal adenocarcinoma